FIELD: medicine, hematology, pharmacy.
SUBSTANCE: invention relates to the development of composition for intravenous administration in treatment or prophylaxis of episodic bleedings and blood coagulability disturbances. The composition comprises factor VIIa and factor XIII and it can comprise inhibitor TFPI additionally. Also, invention relates to a set comprising factor VIIa and factor XIII in dosed formulation and corresponding a pharmaceutically acceptable carrier, using this composition, method for enhanced formation of fibrin clot, method for treatment of episodic bleeding. Invention provides enhancing therapy of episodic bleedings and blood coagulability disturbances.
EFFECT: valuable medicinal properties of composition.
21 cl, 3 dwg, 3 ex
